Fosinopril Sodium And Hydrochlorothiazide
Product Images NDC 54868-5469

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Fosinopril Sodium And Hydrochlorothiazide (NDC 54868-5469). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Physicians Total Care, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fosinopril Sodium Structural Formula (Dfa547a8 Cb88 47e8 B0a7 Ec6cd3950358 01)

Fosinopril Sodium Structural Formula (Dfa547a8 Cb88 47e8 B0a7 Ec6cd3950358 01)
Chemical structure of fosinopril sodium, showing its molecular formula C30H45NNaO7P and molecular weight of 585.65. The structure includes a phenyl ring, phosphonate group, and sodium salt moiety, representing the active ingredient fosinopril sodium.*
FDA Label Image

Hydrochlorothiazide Structural Formula (Dfa547a8 Cb88 47e8 B0a7 Ec6cd3950358 02)

Hydrochlorothiazide Structural Formula (Dfa547a8 Cb88 47e8 B0a7 Ec6cd3950358 02)
Chemical structure of Fosinopril Sodium and Hydrochlorothiazide is shown, featuring a molecular formula and molecular weight of 297.73. The diagram displays atoms and bonds corresponding to the active ingredients in the product by Physicians Total Care, Inc.*
FDA Label Image

Drug-related Incidences Table (Dfa547a8 Cb88 47e8 B0a7 Ec6cd3950358 03)

Drug-related Incidences Table (Dfa547a8 Cb88 47e8 B0a7 Ec6cd3950358 03)
A data table comparing the percentage of various adverse events reported among subjects taking Fosinopril Sodium and Hydrochlorothiazide tablets (N=660) versus a placebo group (N=368). Reported adverse events include headache, cough, fatigue, dizziness, upper respiratory infection, and musculoskeletal pain, each with corresponding percentages for both groups.*
FDA Label Image

Glenmark Logo (Dfa547a8 Cb88 47e8 B0a7 Ec6cd3950358 04)

FDA Label Image

10mg/12.5mg Label (Package Label 01)

10mg/12.5mg Label (Package Label 01)
Label for Physicians Total Care Fosinopril Sodium and Hydrochlorothiazide tablets, USP, containing 10 mg/12.5 mg per tablet. The label indicates a count of 30 tablets and includes cautionary federal law dispensing information. The label also shows lot and expiration details, barcode, and storage instructions.*
FDA Label Image

20mg/12.5mg Label (Package Label 02)

20mg/12.5mg Label (Package Label 02)
Label for Fosinopril Sodium and Hydrochlorothiazide tablets USP, 20 mg / 12.5 mg strength. The package contains 30 tablets. Labeler is Physicians Total Care, Inc. The label includes usage caution, storage instructions, and manufacturing information, along with a barcode and lot/expiration dates.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.